Ticker Details
OraSure Technologies, Inc. OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
IPO Date:	March 17, 1992
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$211.53M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 2.29%
Avg Daily Range (30 D):	$0.10 | 3.23%
Avg Daily Range (90 D):	$0.07 | 2.45%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	.45M
Avg Daily Volume (90 D):	.48M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	130

Institutional Trades
Total Institutional Trades:	1,971
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$.96M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.24M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$1.01M
Avg Closing Volume:	134.4K

News

Apr 3, 2026 @ 7:15 AM Drug Screening Market Trends 2026–2031: Chr... Source: Mordor Intelligence

Feb 3, 2026 @ 1:00 PM OTC/DTC Infectious Disease Diagnostics Research Re... Source: Researchandmarkets.Com

Jan 15, 2026 @ 6:00 PM OraSure Technologies Confirms Receipt of Director ... Source: Orasure Technologies, Inc.

Jan 5, 2026 @ 1:00 PM OraSure Submits CT/NG Molecular Self-Test and Coll... Source: Na

Jan 17, 2025 @ 12:30 AM Global At-Home Testing Market to Reach USD 11,877.... Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.)

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.94	$-.27	$-.94
Diluted EPS	$-.94	$-.27	$-.94
Revenue	$115.02M	$26.76M	$115.02M
Gross Profit	$48.2M	$10.97M	$48.2M
Net Income / Loss	$-68.73M	$-19.29M	$-68.73M
Operating Income / Loss	$-71.97M	$-20.1M	$-71.97M
Cost of Revenue	$66.82M	$15.8M	$66.82M
Net Cash Flow	$-72.78M	$-18.53M	$-72.78M
PE Ratio